Artwork
iconShare
 
Manage episode 479562268 series 1248803
Content provided by Kathy Fettke / RealWealth. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Kathy Fettke / RealWealth or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Roche and Regeneron, two of the world's largest pharmaceutical companies, have announced a combined $56 billion investment that's set to transform U.S. real estate and manufacturing. Billions of dollars will go into expanding research and manufacturing facilities across key states like California, Indiana, New York, and North Carolina, creating thousands of new jobs. These investments signal long-term confidence in the U.S. market and could spark a boom in life sciences real estate. As the pharmaceutical industry navigates potential new tariffs, this expansion is reshaping global supply chains and strengthening biotech hubs in the U.S. Learn how these developments could impact investors and the future of American manufacturing.

Topics Discussed:
  • 00:00 Big Pharma Announcements
  • 00:22 Roche's US Plan
  • 01:01 Regeneron's US Plan
  • 01:55 President Trump's Tariffs
  • 02:15 Other Expansions
  • 02:33 Real Estate Investors

LINKS Download Your Free Top 5 Cities to Invest in 2025 PDF! https://www.realwealth.com/1500 JOIN RealWealth® FOR FREE https://realwealth.com/join-step-1 FOLLOW OUR PODCASTS Real Wealth Show: Real Estate Investing Podcast https://link.chtbl.com/RWS Real Estate News: Real Estate Investing Podcast: https://link.chtbl.com/REN

  continue reading

1170 episodes